RE:LABS Is not SpecialDifference being Lvl is the folks at Medipharm spent the last 5 years laying the long and tricky regulatory groundwork in several parts of the world, and it is slowly starting to pay off as they are starting to get name recognition in the marketplace.
Its taken a lot longer than most of us longs anticipated, but 2024 should be three steps forward / one step back as growing pains are encountered, instead of the almost backwards travel we have seen the past few years.
Those wanting to capitalize by jumping into the fray now will either have to take someone already in out, or wait in the long line of approval processing.
There is absolutely no reason Labs should be trading below a dime with all the irons in the fire................